How to Buy Camp4 Therapeutics Stock
Camp4 Therapeutics Corp
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A.
Camp4 Therapeutics stock last closed at $2.77, up 4.53% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Camp4 Therapeutics stock is currently +112.26% from its 52-week low of $1.31, and -77.48% from its 52-week high of $12.30.
There are currently 20.16M shares of CAMP outstanding. The market cap of CAMP is $55.85M. In the last 24 hours, 483,000 CAMP shares were traded.
How to Buy Camp4 Therapeutics Stock
Wondering how to invest in Camp4 Therapeutics stock? Here's how.
- Choose where to buy Camp4 Therapeutics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Camp4 Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Select your method of payment and add your information.
- Evaluate Camp4 Therapeutics stock: The Camp4 Therapeutics ticker symbol is CAMP. Is Camp4 Therapeutics stock a good investment? Should you buy shares of CAMP? How do CAMP's underlying business fundamentals look? Do top analysts think Camp4 Therapeutics is a good buy? Why has CAMP's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if CAMP is a good stock to buy).
- Make your CAMP buy order: Decide if you will purchase CAMP shares at the current market price or use a limit order to purchase CAMP stock at a particular price.
- Monitor your CAMP investment: Create a watchlist to important notifications about your position in Camp4 Therapeutics shares.
Step 1: Choose where to buy Camp4 Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy CAMP shares.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Tech to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you can invest in CAMP today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new brokerage account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've finished signing up on the best stock investing app, you can securely and quickly fund your account:
Check out the walkthrough below to see the process of depositing funds into your brokerage account.
Step 4: Evaluate Camp4 Therapeutics stock
Once you have identified the best place to buy Camp4 Therapeutics stock, it's crucial to research their stock before you invest, so you can comprehend the risk and opportunity.
Overview of key CAMP info
Camp4 Therapeutics Fundamentals
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on CAMP's stock page.
How is CAMP stock valued?
You can use many financial metrics, analyses, models, and charts to gauge CAMP's intrinsic value.
Using relative valuations metrics:
- CAMP may be undervalued based on its P/E ratio of 0.07x, relative to Biotechnology industry P/E ratio of -95.43x
- CAMP could be undervalued based on its P/B ratio of 1.4x, relative to Biotechnology industry P/B ratio of 4.68x
You can do more valuation analysis on CAMP's stock here.
CAMP Financial Health Overview
Signs that CAMP is financially healthy:
- There are more short-term assets than long-term liabilities on the CAMP balance sheet.
- There are more short-term assets than short-term liabilities on the CAMP balance sheet.
- CAMP has a low debt to equity ratio of 0.28.
Signs that CAMP is not financially healthy:
- CAMP has $40.68M in cash and short term investments. This is not enough to cover its annual cash burn of $46.15M.
- CAMP has cash burn of 46152000. It does not have sufficient cash and short-term investments to cover this.
- CAMP profit margin has gone up by 124.82 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy Camp4 Therapeutics stock, according to Wall Street analysts?
Out of 2 Wall Street analysts who track CAMP, the consensus analyst rating on CAMP is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Camp4 Therapeutics stock forecast page.
CAMP Technical Indicators
CAMP Performance Metrics
Last year, CAMP revenue was $3.01M. During the last one years, CAMP's revenue has gone up by 759.14% per year. This was faster than the Biotechnology industry average of 67.22%.
Dig into CAMP's earnings and revenue performance here.
Are CAMP executives and large shareholders buying or selling the stock?
In the past 12 months, executives and large shareholders at CAMP have bought more shares than they have sold.
5am Partners VI LLC, 10% Owner of CAMP, was the latest CAMP insider to buy. They bought $4,499,999.28 worth of CAMP shares on Sep 11, 2025.
Research more about who owns CAMP stock here.
Can I get consistent income from CAMP stock?
No, Camp4 Therapeutics doesn't provide an income stream by paying out dividends.
CAMP Social Trading Data
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your CAMP buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, use a limit order.
Hit the Open Trade button and your broker will place the order.
If you need additional assistance investing in stocks on eToro, watch the how to video below:
Step 6: Monitor your CAMP investment
Now that you own some CAMP stock, you'll want to stay up-to-date on your stock purchase.
Create a watchlist to keep track of your CAMP stock.
CAMP Feed
How to Buy Stock in Camp4 Therapeutics
To summarize, here are the 6 steps you need to take to buy Camp4 Therapeutics stock right now:
- Choose where to buy Camp4 Therapeutics stock
- Open your brokerage account
- Put funds into your investment account
- Evaluate Camp4 Therapeutics stock
- Make your CAMP buy order
- Monitor your CAMP investment
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Camp4 Therapeutics, hit the button below to create your watchlist.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.